Single-cell Omics Market - Top Companies and Manufacturers

Companies Dominating the Single-cell Omics Market

Ultima Genomics, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
10x Genomics, Inc.
Becton, Dickinson and Company (BD)
CELLENION
PerkinElmer Inc.
ANGLE plc
Illumina, Inc.
Bio-Rad Laboratories, Inc.
Mission Bio, Inc.
Standard BioTools Inc.

Browse Key Market Insights with Data Illustration:

Single-cell Omics Market Size, Forecast Report 2035

In the News

Ultima Genomics, Inc. announced the partnership with 10x Genomics. With this collaboration, the ultra-high throughput sequencing systems will be using chromium single-cell gene expression solutions of 10X Genomics. Both organizations will give researchers optimized, cost-effective methods to enable larger-scale gene expression analysis in single cells.
Mission Bio, Inc. collaborated with Fulent Genetics. By the help of Mission Bio, Fulgent Genetics will be able to offer Pharma drug developers single-cell multi-omics for biomarker identification, clinical research, and single-cell MRD creation at large scale

Frequently Asked Questions (FAQ)

Increasing incidences of cancer, rising investment in cell therapy, and technological advancement of single-cell techniques are the major factors driving the market growth.

The market size of single-cell omics is anticipated to attain a CAGR of around 22% over the forecast period, i.e., 2023 â€“ 2035.

The major players in the market are 10x Genomics, Inc., Becton, Dickinson and Company (BD), CELLENION, PerkinElmer Inc., ANGLE plc, Illumina, Inc., Bio-Rad Laboratories, Inc., Mission Bio Inc., Standard BioTools Inc. and Ultima Genomics, Inc.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by application, product, end user, and by region.

The oncology segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

There is no standardization and the higher cost of single-cell omics is estimated to be the growth hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

Single-cell Omics Market - Top Companies and Manufacturers

Companies Dominating the Single-cell Omics Market

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What are the major factors driving the growth of the single-cell omics market?

What would be the CAGR of the single-cell omics market over the forecast period?

Who are the major players dominating the single-cell omics market?

How are the company profiles selected?

What are the segments in the single-cell omics market?

Which segment captures the largest market size in the application segment in the single-cell omics market?

What are the challenges affecting the market growth?

Which region will provide more business opportunities for the growth of the single-cell omics market in the future?